Archives

Optimizing Staffing to Support Growth and Excellence 204 115 Shields Health Solutions

Optimizing Staffing to Support Growth and Excellence
A staffing model developed in conjunction with Excelera led to a more fully integrated standard of care for specialty patients. Prior authorization workflow improvements eased the administrative burden on providers, and the number of prescriptions filled internally grew.
Moving away from dependence on a third-party vendor 204 115 Shields Health Solutions

Moving away from dependence on a third-party vendor
Medication adherence and customer service improved after the new in-house entity, Proprium Pharmacy, was established. The engagement included advisory, project management and SME assistance for the specialty pharmacy and home delivery design, build-out and implementation, including related pharmacy support operations.
Gaining access to a limited distribution network 204 115 Shields Health Solutions

Gaining access to a limited distribution network
Excelera helped Regional Health (now Monument Health) develop data capabilities required to gain access to certain limited-distribution breast, kidney and lung cancer drugs from Pfizer. Integrated specialty pharmacy care and greater convenience benefit the health system’s oncology patients.
Helping Montana’s Largest Health System Develop and Implement Their Specialty Pharmacy Opportunity 194 82 Shields Health Solutions

Helping Montana’s Largest Health System Develop and Implement Their Specialty Pharmacy Opportunity
This engagement began with the development of a specialty pharmacy business model and pro forma to demonstrate viability. Planning and support for build-out, drug access, clinical therapy management, a call center and other functions followed, resulting in a successful launch.
Implementing In-house Specialty Pharmacy Capabilities 220 53 Shields Health Solutions

Implementing In-house Specialty Pharmacy Capabilities
With an extensive engagement that included a focus on best practice clinical therapy management programs, data collection and aggregation, and URAC accreditation, Excelera helped Avera Health build a thriving business to compete successfully with large, national specialty pharmacies.
Health Systems Working Together Strengthen Their In-House Specialty Pharmacy Capabilities and Optimize Patient Care 204 115 Shields Health Solutions

Health Systems Working Together Strengthen Their In-House Specialty Pharmacy Capabilities and Optimize Patient Care

This white paper provides background on the specialty pharmacy market, describes the role of health systems in specialty pharmacy care, acknowledges the challenges they face, and outlines the benefits of…

Excelera® Welcomes Diane Wolfe as National Director of Manufacturer Relations 204 115 Shields Health Solutions

Excelera® Welcomes Diane Wolfe as National Director of Manufacturer Relations
Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
Excelera Announces Key Hires to Support Expanded Product and Service Offerings 204 115 Shields Health Solutions

Excelera Announces Key Hires to Support Expanded Product and Service Offerings
Updates include additions to the leadership team, enhanced technology platform capabilities to track electronic health record data and expanded product portfolio
New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia 150 150 Shields Health Solutions

New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia
Erin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care 150 150 Shields Health Solutions

Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care
By Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.